» Articles » PMID: 11286325

Bioadhesion: New Possibilities for Drug Administration?

Overview
Specialty Pharmacology
Date 2001 Apr 5
PMID 11286325
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Bioadhesion (and mucoadhesion) is the process whereby synthetic and natural macromolecules adhere to mucosal surfaces in the body. If these materials are then incorporated into pharmaceutical formulations, drug absorption by mucosal cells may be enhanced or the drug released at the site for an extended period of time. For synthetic polymers, such as the chitosans, carbopols and carbomers, the mechanism of bio/mucoadhesion is the result of a number of different physicochemical interactions. Biological bio/mucoadhesives, such as plant lectins, show specific interactions with cell surfaces and mucin and are seen as the 'second generation' bioadhesives. Bioadhesive systems for drug administration via the buccal and nasal cavities are nearing the market; in the case of nasal bioadhesion, bioadhesive microparticles are used. A bioadhesive formulation for drug administration to the vagina is in use. The gastrointestinal tract is proving a more difficult site because of the rapid turnover of mucus, and relatively constant transit time, but intensive research is in progress. Micro- and nano-particles, coated with either bio/mucoadhesive polymers or specific biological bioadhesives, are showing some promise, but will require considerable research and development before reaching the market.

Citing Articles

Cysteine Conjugation: An Approach to Obtain Polymers with Enhanced Muco- and Tissue Adhesion.

Chroszcz-Porebska M, Gadomska-Gajadhur A Int J Mol Sci. 2024; 25(22).

PMID: 39596243 PMC: 11594736. DOI: 10.3390/ijms252212177.


Enzyme-Triggered Intestine-Specific Targeting Adhesive Platform for Universal Oral Drug Delivery.

Li Y, Lee J, Kirtane A, Li M, Coffey 3rd C, Hess K Adv Healthc Mater. 2023; 12(27):e2301033.

PMID: 37314859 PMC: 10653991. DOI: 10.1002/adhm.202301033.


Physicochemical properties of otic products for Canine Otitis Externa: comparative analysis of marketed products.

Song Y, Abdella S, Afinjuomo F, Weir E, Tan J, Hill P BMC Vet Res. 2023; 19(1):39.

PMID: 36759841 PMC: 9909939. DOI: 10.1186/s12917-023-03596-2.


Utilization of propranolol hydrochloride mucoadhesive invasomes as a locally acting contraceptive: , and evaluation.

Teaima M, Eltabeeb M, El-Nabarawi M, Abdellatif M Drug Deliv. 2022; 29(1):2549-2560.

PMID: 35912869 PMC: 9347470. DOI: 10.1080/10717544.2022.2100514.


Construction and Evaluation of Chitosan-Based Nanoparticles for Oral Administration of Exenatide in Type 2 Diabetic Rats.

Yang J, Wu L, Lin M, Lu Y, Wang T, Han M Polymers (Basel). 2022; 14(11).

PMID: 35683851 PMC: 9183037. DOI: 10.3390/polym14112181.


References
1.
Davis S, Hardy J, Fara J . Transit of pharmaceutical dosage forms through the small intestine. Gut. 1986; 27(8):886-92. PMC: 1433369. DOI: 10.1136/gut.27.8.886. View

2.
Brown D, Henzl M, Kaufman R . Butoconazole nitrate 2% for vulvovaginal candidiasis. New, single-dose vaginal cream formulation vs. seven-day treatment with miconazole nitrate. Gynazole 1 Study Group. J Reprod Med. 1999; 44(11):933-8. View

3.
Beyssac E, Touaref F, Meyer M, Jacob L, Sandouk P, Aiache J . Bioavailability of morphine after administration of a new bioadhesive buccal tablet. Biopharm Drug Dispos. 1998; 19(6):401-5. DOI: 10.1002/(sici)1099-081x(199809)19:6<401::aid-bdd116>3.0.co;2-u. View

4.
Lee J, Park J, Robinson J . Bioadhesive-based dosage forms: the next generation. J Pharm Sci. 2000; 89(7):850-66. DOI: 10.1002/1520-6017(200007)89:7<850::AID-JPS2>3.0.CO;2-G. View

5.
Ugwoke M, Agu R, Jorissen M, Augustijns P, Sciot R, Verbeke N . Nasal toxicological investigations of Carbopol 971P formulation of apomorphine: effects on ciliary beat frequency of human nasal primary cell culture and in vivo on rabbit nasal mucosa. Eur J Pharm Sci. 2000; 9(4):387-96. DOI: 10.1016/s0928-0987(99)00082-2. View